Essiac Tea

Description

Essiac tea is based on a Canadian Ojibwa Indian formula containing primarily burdock root (Arctium lappa), Turkish rhubarb root (Rheum palmatum), sheep sorrel (Rumex acetosella), and the inner bark of the slippery elm (Ulmus fulva or Ulmus rubra). It is used in alternative medicine mainly as a treatment for cancer.

The formula is said to have been first developed by an Ojibwa healer to purify the body and balance the spirit. In 1922, the formula came to the attention of Rene Caisse (essiac is Caisse spelled backwards), a nurse in Ontario, Canada, after hearing first-hand accounts of it curing cancer. She began administering the tea to cancer patients and found it to have remarkable healing abilities. She continued treating cancer patients with the tea until she died in 1978. In 1977, Caisse sold the essiac tea formula to the Resperin Corp. of Ontario, Canada.

Caisse reported that hundreds of her patients had been cured of their cancers through the use of her tea, sometimes used as intramuscular injections. Most of the patients came to her after conventional cancer treatments (surgery, chemotherapy, and radiation therapy) failed. Several alternative health care practitioners report essiac tea seems to work best in patients who have had the least amount of radiation therapy or chemotherapy.

The mainstream medical community does not embrace essiac tea. Critics contend that a certain number of cancers deemed incurable spontaneously go into remission without an adequate medical explanation as to why. Others chalk up the successes to the so-called placebo effect, where the belief that the treatment is working effects a cure rather than the treatment itself. The treatment is not approved by the American Medical Association or the American Cancer Society.

In 1938, a bill in the Canadian Parliament to legalize essiac tea failed by three votes. It is still not approved for marketing in the United States or Canada. However, the Canadian Health and Welfare Department permits compassionate use of essiac tea on an emergency basis.

In 1975 and again in 1982, the Memorial Sloan-Kettering Cancer Center in New York tested only the sorrel component in the tea. They boiled it which may have neutralized any beneficial compounds in the leftover tea and administered it to mice with cancerous tumors. It determined the formula had no anticancer effects. The National Cancer Institute and Canadian Bureau of Prescription Drugs reached the same conclusion in the 1980s.


Advertisement
Advertisement